Main sponsor STADA celebrates with the RSV Lahn-Dill: Wheelchair basketball team concludes successful season
- Press Release
Bad Vilbel, May 8, 2013 –
STADA Arzneimittel AG congratulates the RSV Lahn-Dill on its successful season. After winning the league championship and Cup double, the wheelchair basketball team closed out their schedule by participating in the Champions League finals in Valladolid, Spain. The wheelchair basketball players from Wetzlar were previously once again able to celebrate the Cup and league championship double. STADA has been supporting the RSV Lahn-Dill for nearly 20 years.
Overall, the RSV has won the league championship and cup ten times. The team has also managed to win the Champion's League a total of five times. In 2010, the team also won the World Cup in Japan. Manager Andreas Joneck emphasizes: "Strong partners like STADA create the conditions that are necessary for this success and are therefore extremely important for us as a team."
The commitment to both mass participation sport and high-performance sport is firmly anchored in STADA's self image. As a company with a high degree of competence and a long tradition in the area of health, STADA uses its activities to draw attention to the importance of sport and exercise for the well-being of all people. In addition to the RSV Lahn-Dill, STADA supports a number of other athletes through its subsidiaries. These include, for example, a German triathlon team, the Paralympic gold-medal winner in dressage Hanne Brenner and Frankfurt's first-division football team, the Eintracht.
About STADA Arzneimittel AG
STADA Arzneimittel AG is a publicly-listed company with headquarters in Bad Vilbel, Germany. STADA consistently focuses on a multi-pillar strategy of generics and branded products (OTC) with an increasingly international market orientation. The Group traditionally has a strong presence in Europe and is the only independent generics producer in Germany. Worldwide, STADA is one of the five leading companies in the generics industry and is represented in more than 30 countries with approximately 50 subsidiaries. Branded products such as Mobilat, Grippostad and Ladival are among the highest selling in their product category in Germany. In financial year 2012, STADA achieved Group sales of Euro 1,837.5 million, adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of Euro 367.5 million and adjusted net income of Euro 147.9 million. As of December 31, 2012, STADA employed 7,761people worldwide.
For more information, please contact:
STADA Arzneimittel AG
D-61118 Bad Vilbel
Tel.: +49 6101 603-165
Fax: +49 6101 603-506